- NovaBay Pharmaceuticals has rebranded to Stablecoin Development Corporation and shifted from healthcare into a DeFi-focused business model
- The company raised $134 million to accumulate SKY governance tokens tied to the Sky protocol and its USDS stablecoin, and is staking for on-chain rewards
NovaBay Pharmaceuticals, a nanocap company previously focused on healthcare, has reoriented its business into digital assets and decentralized finance, rebranding as Stablecoin Development Corporation and adopting the ticker SDEV. The shift places the former NovaBay Pharmaceuticals at the center of a strategy built around the Sky protocol and its associated stablecoin ecosystem.
NovaBay Pharmaceuticals rebrands into Stablecoin Development Corporation
The company, which has a market capitalization of about $30 million, has formally abandoned its former identity as NovaBay Pharmaceuticals and now presents itself as Stablecoin Development Corporation. The rebrand accompanies a complete pivot from healthcare operations to a crypto-focused model centered on acquiring and deploying governance tokens in a decentralized finance protocol.
This transition follows a $134 million private placement that brought in capital from crypto-native backers such as Framework Ventures and Tether Investments. The funding round provides the financial base for the new entity’s activities in DeFi, including building exposure to governance tokens and participating in protocol economics through staking.
Building a major position in SKY and USDS exposure
Stablecoin Development Corporation is channeling the proceeds of the private placement into the Sky protocol, a decentralized finance system that issues USDS, a dollar-pegged stablecoin backed by cryptocurrencies. The company’s approach is to accumulate SKY, the protocol’s governance token, giving it both economic exposure and potential influence over future decisions affecting USDS and the broader ecosystem.
According to the company, it currently holds about 2.06 billion SKY tokens, representing roughly 8.78% of the total supply and valued at around $147 million. More than half of this position was built through open market purchases at an average price near $0.065 per token. The remaining tokens were obtained as part of the financing structure, which included a mix of cash and stablecoins rather than traditional equity-only funding.
By concentrating its balance sheet in SKY, the former NovaBay Pharmaceuticals is effectively tying its fortunes to the growth and governance of the Sky protocol and its stablecoin product. This move makes SDEV one of the largest known single holders of SKY tokens and a notable listed proxy for the protocol’s performance.
Staking strategy and DeFi yield participation
Beyond passive token ownership, Stablecoin Development Corporation has started to stake its SKY holdings to earn on-chain rewards. The company reports that it has received roughly 26.6 million SKY tokens in staking rewards so far. These payouts are not fixed, as they depend on the protocol’s staking rules, participation levels, and wider network parameters.
The Sky protocol, which evolved from MakerDAO, currently advertises a SKY staking rate of over 10% on its website. That rate helps explain the appeal for large holders such as SDEV, which can convert a substantial governance stake into a recurring yield stream. Staking also signals long-term alignment with the protocol, since tokens are committed to securing and participating in the system rather than being treated purely as a trading asset.
Market performance, however, has been subdued in the short term. The value of SKY is down around 1.45% over the last 24 hours, even as the broader crypto market, as tracked by the CoinDesk 20 (CD20) index, rose 4% in the same period. This divergence highlights that protocol-specific tokens can trade independently of wider market moves, a factor that will be relevant for equity investors assessing SDEV’s new risk profile.
CoinDesk has requested comment from Stablecoin Development Corporation but had not received a response at the time of writing, leaving some open questions on how actively the company plans to engage in protocol governance and future DeFi initiatives.
Conclusion
The transformation of NovaBay Pharmaceuticals into Stablecoin Development Corporation marks a rare public-market example of a traditional nanocap abandoning its legacy sector to become a DeFi-focused vehicle. Backed by $134 million in private financing and large positions in SKY tied to the USDS stablecoin protocol, SDEV is positioning itself as a major governance and staking participant in the Sky ecosystem. Its strategy links shareholder outcomes directly to the evolution of a single decentralized protocol and underscores how legacy corporates can pivot into crypto-native business models built around governance tokens and on-chain yields.
Disclaimer
The information provided in this article is for informational purposes only and should not be considered financial advice. The article does not offer sufficient information to make investment decisions, nor does it constitute an offer, recommendation, or solicitation to buy or sell any financial instrument. The content is opinion of the author and does not reflect any view or suggestion or any kind of advise from cryptonewsbytes.com. The author declares he does not hold any of the above mentioned tokens or received any incentive from any company.
Featured image created by AI
